Jih-Hwa Guh Selected Research

Terazosin (Hytrin)

6/2011	Anti-angiogenic effects and mechanism of prazosin.
10/2007	Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle.
2/2003	Identification of apoptotic and antiangiogenic activities of terazosin in human prostate cancer and endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jih-Hwa Guh Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 02/2003
53	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 09/2002
18	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 03/2004
8	Leukemia 04/2020 - 05/2004
7	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2004
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 07/2003
6	Inflammation (Inflammations) 12/2020 - 07/2002
5	Colorectal Neoplasms (Colorectal Cancer) 12/2008 - 12/2006
4	Lung Neoplasms (Lung Cancer) 08/2020 - 06/2010
3	Mitochondrial Diseases (Mitochondrial Disease) 06/2020 - 01/2005
3	Hyperplasia 06/2011 - 06/2003
2	Triple Negative Breast Neoplasms 01/2019 - 11/2011
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2018 - 09/2013
2	Cardiotoxicity 01/2018 - 02/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 01/2015
2	Glioblastoma (Glioblastoma Multiforme) 09/2015 - 05/2014
2	Neoplasm Metastasis (Metastasis) 03/2015 - 11/2007
2	Hypoxia (Hypoxemia) 11/2011 - 09/2009
2	Vascular System Injuries 12/2008 - 06/2003
2	Acute Promyelocytic Leukemia 10/2005 - 01/2005
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020

Drug/Important Bio-Agent (IBA)

30	Hormones (Hormone)IBA 01/2019 - 02/2004
12	TubulinIBA 01/2020 - 09/2002
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2007
7	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 10/2007
6	Pharmaceutical PreparationsIBA 01/2022 - 05/2005
6	Proteins (Proteins, Gene)FDA Link 06/2020 - 01/2005
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2014 - 12/2006
6	AndrogensIBA 05/2011 - 09/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 09/2002
4	Biological ProductsIBA 12/2020 - 02/2007
4	Adenosine Triphosphatases (ATPase)IBA 11/2020 - 12/2013
4	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 06/2020 - 09/2009
4	Cardiac GlycosidesIBA 01/2020 - 09/2002
4	NF-kappa B (NF-kB)IBA 08/2010 - 10/2005
4	evodiamineIBA 09/2009 - 05/2004
3	LipidsIBA 10/2021 - 06/2010
3	Phosphotransferases (Kinase)IBA 10/2021 - 12/2011
3	MK 2206IBA 01/2019 - 01/2015
3	CytokinesIBA 01/2019 - 05/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 05/2005
3	Peptides (Polypeptides)IBA 11/2017 - 02/2015
3	Ouabain (G Strophanthin)IBA 09/2015 - 09/2002
3	Matrix Metalloproteinases (MMPs)IBA 03/2015 - 01/2006
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 11/2014 - 07/2012
3	CaspasesIBA 01/2014 - 02/2008
3	CamptothecinIBA 07/2012 - 09/2009
3	Terazosin (Hytrin)FDA LinkGeneric 06/2011 - 02/2003
3	lissamine rhodamine B (sulforhodamine B)IBA 05/2011 - 10/2005
3	bromovulone IIIIBA 08/2006 - 04/2004
3	ProstaglandinsIBA 08/2006 - 01/2005
3	IndazolesIBA 01/2006 - 03/2005
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2015
2	CholesterolIBA 10/2021 - 01/2018
2	4-toluenesulfonamideIBA 10/2021 - 01/2018
2	TriazolesIBA 04/2020 - 11/2016
2	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 09/2002
2	artenimol (dihydroartemisinin)IBA 01/2020 - 01/2019
2	CardenolidesIBA 01/2020 - 01/2014
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 01/2019
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020 - 01/2018
2	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 01/2018
2	SaponinsIBA 01/2018 - 02/2014
2	Histone Deacetylase InhibitorsIBA 01/2018 - 09/2013
2	Topoisomerase II InhibitorsIBA 01/2018 - 02/2008
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 09/2015 - 08/2012
2	reevesioside FIBA 09/2015 - 12/2013
2	AnthraquinonesIBA 11/2014 - 02/2008
2	Histone Deacetylases (Histone Deacetylase)IBA 08/2014 - 09/2013
2	GlycosidesIBA 05/2014 - 01/2014
2	Glutathione (Reduced Glutathione)IBA 05/2014 - 05/2014
2	SurvivinIBA 04/2014 - 01/2013
2	TriterpenesIBA 02/2014 - 01/2006
2	antroquinonolIBA 08/2012 - 01/2010
2	Protein Kinases (Protein Kinase)IBA 11/2011 - 07/2008
2	Transcription Factors (Transcription Factor)IBA 11/2011 - 03/2007
2	Prazosin (Minipress)FDA LinkGeneric 06/2011 - 10/2007
2	Doxazosin (Cardura)FDA LinkGeneric 06/2011 - 10/2007
2	Endoplasmic Reticulum Chaperone BiPIBA 05/2011 - 11/2009
2	Cyclooxygenase InhibitorsIBA 08/2010 - 07/2002
2	dendrophenolIBA 06/2010 - 07/2008
2	Etoposide (VP 16)FDA LinkGeneric 11/2009 - 02/2008
2	TunicamycinIBA 11/2009 - 04/2008
2	Plant ExtractsIBA 11/2009 - 01/2006
2	denbinobinIBA 11/2008 - 01/2005
2	2-phenyl-4-oxohydroquinolineIBA 02/2008 - 06/2007
2	GenisteinIBA 03/2007 - 06/2004
2	cyclopentenoneIBA 08/2006 - 01/2005
2	AlkaloidsIBA 01/2005 - 05/2004
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	ChalconesIBA 12/2020
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 11/2020
1	verucopeptinIBA 11/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2020
1	PhosphoproteinsIBA 08/2020
1	Cyclin B1IBA 08/2020

Therapy/Procedure

12	Therapeutics 10/2021 - 09/2002
11	Drug Therapy (Chemotherapy) 10/2021 - 01/2005
7	Castration 10/2021 - 09/2015
2	Oral Administration 11/2011 - 10/2007